Fundamental Analysis of VACCITECH PLC(NASDAQ:VACC) stock

Fundamental Rating

Taking everything into account, VACC scores 3 out of 10 in our fundamental rating. VACC was compared to 588 industry peers in the Biotechnology industry. VACC has a great financial health rating, but its profitability evaluates not so good. VACC is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year VACC has reported negative net income.

In the past year VACC has reported a negative cash flow from operations.

1.2 Ratios

VACC has a better Return On Assets (-22.32%) than 80.10% of its industry peers.

VACC's Return On Equity of -25.29% is amongst the best of the industry. VACC outperforms 83.25% of its industry peers.

		Industry Rank	Sector Rank
ROA	-22.32%
ROE	-25.29%
ROIC	N/A

ROA(3y)-17.03%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VACC so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

VACC does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, VACC has more shares outstanding

There is no outstanding debt for VACC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 3.18 indicates that VACC is not in any danger for bankruptcy at the moment.

VACC has a better Altman-Z score (3.18) than 76.29% of its industry peers.

There is no outstanding debt for VACC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	3.18

ROIC/WACCN/A

WACC9.06%

2.3 Liquidity

A Current Ratio of 15.26 indicates that VACC has no problem at all paying its short term obligations.

The Current ratio of VACC (15.26) is better than 88.06% of its industry peers.

VACC has a Quick Ratio of 15.26. This indicates that VACC is financially healthy and has no problem in meeting its short term obligations.

Looking at the Quick ratio, with a value of 15.26, VACC belongs to the top of the industry, outperforming 88.23% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	15.26
Quick Ratio	15.26

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

VACC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -4723.33%.

The Revenue for VACC has decreased by -58.53% in the past year. This is quite bad

VACC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 86.87% yearly.

EPS 1Y (TTM)-4723.33%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-251.22%

Revenue 1Y (TTM)-58.53%

Revenue growth 3Y86.87%

Revenue growth 5YN/A

Revenue growth Q2Q-98.04%

3.2 Future

The Earnings Per Share is expected to decrease by -98.17% on average over the next years. This is quite bad

VACC is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -60.57% yearly.

EPS Next Y-1733.53%

EPS Next 2Y-304.24%

EPS Next 3Y-153.1%

EPS Next 5Y-98.17%

Revenue Next Year-95.74%

Revenue Next 2Y-84.84%

Revenue Next 3Y-75.62%

Revenue Next 5Y-60.57%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

VACC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year VACC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

VACC's earnings are expected to decrease with -153.10% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-304.24%

EPS Next 3Y-153.1%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for VACC!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

VACCITECH PLC

NASDAQ:VACC (11/6/2023, 7:00:01 PM)

After market: 4.9 -0.1 (-2%)

+0.51 (+11.36%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap192.73M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-22.32%
ROE	-25.29%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.05

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	15.26
Quick Ratio	15.26
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-4723.33%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y-1733.53%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-58.53%

Revenue growth 3Y86.87%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

VACCITECH PLC (VACC)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens